# Blood Brain Barrier Penetration and Pharmacokinetics of the Elemene in Malignant Patients.

> **NCT01679847** · — · UNKNOWN · sponsor: **Dalian Holley Kingkong Pharmaceutical Co., Ltd** · enrollment: 8 (estimated)

## Conditions studied

- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01679847
- **Lead sponsor:** Dalian Holley Kingkong Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2013-04
- **Final completion:** 2013-06
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2012-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01679847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01679847, "Blood Brain Barrier Penetration and Pharmacokinetics of the Elemene in Malignant Patients.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01679847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*